News | Cardiovascular Ultrasound | April 30, 2019

New Guideline Published for Evaluation of Valvular Regurgitation After Catheter-based Valve Interventions

Document outlines technical considerations and imaging techniques as catheter-based valve interventions continue to increase

New Guideline Published for Evaluation of Valvular Regurgitation After Catheter-based Valve Interventions

April 30, 2019 — A new document compiled by four cardiac imaging professional societies provides a resource to guide clinicians in best practices for assessing valvular regurgitation following catheter-based repair or replacement of a valve. The document, available in full here, supplements the previously published guideline Recommendations for Evaluation of Prosthetic Valves with Echocardiography and Doppler Ultrasound.

Valvular regurgitation is a prevalent cardiac disorder, in which one or more of the heart’s valves leak, often leading to extra burdens on the heart muscle and requiring treatment. Catheter-based interventions to treat valvular heart disease (VHD) have increased over the past few years with the advent of transcatheter aortic valve replacement (TAVR), edge-to-edge mitral valve repair, and other investigative devices to repair or replace diseased valves. Guidelines to assess the results of these interventions, however, are lacking.

ASE’s Chair of the writing group, William A. Zoghbi, M.D., MACC, FASE, of Houston Methodist DeBakey Heart & Vascular Center in Houston, Texas, commented, “This new guideline is timely, as cardiologists and valvular heart disease specialists need consensus on how to evaluate results of catheter-based valve repair or replacement — novel approaches that help many patients with valve disease.”

Echocardiography is essential in the evaluation of valvular regurgitation after percutaneous interventions and is the first-line tool for evaluation of procedural results. Its assessment, however, is more difficult than in native valvular regurgitation because of the multitude of procedures and hardware involved. This highlights the need for an integrative approach of all information gleaned from various parameters.   

The document outlines in detail the technical considerations and imaging techniques, as well as the value that 3-D echocardiography and cardiac magnetic resonance imaging can add to the diagnostic process. It delves into specific issues with each type of regurgitation, namely mitral regurgitation (MR), aortic regurgitation (AR), tricuspid regurgitation (TR) and pulmonary regurgitation (PR). The document includes nine useful tables summarizing techniques and advantages of each modality, as well as 23 figures to illustrate various concepts.

In conjunction with the publication of this guideline Zoghbi will conduct a live webinar, including a question and answer section in June 2019. The webinar will be available for free to all American Society of Echocardiography (ASE) members and open to all other clinicians for $25. Registration and all ASE-hosted guideline webinars are available on ASEUniversity.org.

The full guideline document is available on the Journal of American Society of Echocardiography (JASE) website.

For more information: www.asecho.org

Related Content

MRI Metal Artifact Reduction Poses Minimal Thermal Risk to Hip Arthroplasty Implants
News | Magnetic Resonance Imaging (MRI) | May 23, 2019
Clinical metal artifact reduction sequence (MARS) magnetic resonance imaging (MRI) protocols at 3 Tesla (3T) on hip...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Baylor Scott White Heart Hospital Siemens Flash CT system used for dedicated cardiac CT scans, CCTA, CTA.
360 Photos | CT Angiography (CTA) | May 20, 2019
This is a 360 degree photo of a Siemens Somatom Force 64-slice, dual-source computed tomography (CT) system installed
360 Photos | Cardiac Imaging | May 20, 2019
A 360 degree photo view of a Siemens Healthineers digital radiography (DR) room install and mobile Carestream DRX mob
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas.
360 Photos | Angiography | May 17, 2019
This is a view inside one of the 11 cath labs at ...
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition X 1.5T MR, the world’s...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...